Household endotoxin levels and the risk of non-Hodgkin lymphoma
- PMID: 23277417
- PMCID: PMC3800025
- DOI: 10.1007/s10552-012-0121-9
Household endotoxin levels and the risk of non-Hodgkin lymphoma
Abstract
Objective: Endotoxin, a component of the outer membrane of gram-negative bacteria, elicits a strong innate and inflammatory immune response associated with the secretion of proinflammatory cytokines, including tumor necrosis factor-alpha (TNF-α). Because TNF-α polymorphisms that increase TNF-α production are associated with an increased risk of non-Hodgkin lymphoma (NHL), we hypothesized that increased levels of household endotoxin would be associated with an increased NHL risk.
Methods: We evaluated this association in the National Cancer Institute/Surveillance, Epidemiology and End Results (NCI/SEER) NHL multicenter population-based case-control study. Used vacuum cleaner bags were collected from participants during a home interview. Dust samples from the bags of 594 cases and 442 controls were analyzed for endotoxin [endotoxin unit (EU)/mg of dust] using the kinetic chromogenic Limulus amebocyte lysate assay. Multivariable logistic regression was used to estimate the effect of endotoxin on NHL risk adjusted for age, sex, race, education, study center, and farm exposure.
Results: Endotoxin was not associated with NHL overall [odds ratio (OR) for highest quartile of endotoxin levels = 0.81, 95 % confidence interval (CI) = 0.55, 1.20; p for trend = 0.35] or with diffuse large B-cell lymphoma (OR = 0.63, 95 % CI = 0.34, 1.16; p = 0.31) or follicular lymphoma (OR = 1.07, 95 % CI = 0.61, 1.89; p = 0.73) subtypes. Both working and living on a farm were associated with higher household endotoxin levels compared to never working (p = 0.009) or living (p = 0.01) on a farm. Excluding farmers from the analysis did not change the results.
Conclusions: We found no evidence of a role for household endotoxin in NHL etiology.
References
-
- Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:405–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U55/CCR921930-02/PHS HHS/United States
- N01 PC067009/CN/NCI NIH HHS/United States
- P30 ES007048/ES/NIEHS NIH HHS/United States
- P01 CA17054/CA/NCI NIH HHS/United States
- P30 ES005605/ES/NIEHS NIH HHS/United States
- N01-PC-35139/PC/NCI NIH HHS/United States
- N01 PC067008/PC/NCI NIH HHS/United States
- N01 PC035139/CA/NCI NIH HHS/United States
- P30 ES07048/ES/NIEHS NIH HHS/United States
- P30 CA014089/CA/NCI NIH HHS/United States
- ZIA CP010125/ImNIH/Intramural NIH HHS/United States
- P01 CA017054/CA/NCI NIH HHS/United States
- N01-PC67009/PC/NCI NIH HHS/United States
- N01 PC065064/PC/NCI NIH HHS/United States
- N01-PC-71105/PC/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
